跳至主要内容
临床试验/IRCT201410289819N5
IRCT201410289819N5已完成2 期

Evaluation of Therapeutic Effects of variopeptyl (Iranian Formulated LHRH agonist) in patients with Metastatic Prostate Cancer

Vice chancellor for research Tehran University of Medical Sciences0 个研究点目标入组 47 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
47

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Male

入选标准

  • Inclusion Criteria: All patients with metastatic prostate cancer without age limitation who are referred to urology clinic of Imam Khomeyni Hospital, Filling consent form and Not receiving hormone therapy before
  • Exclusion Criteria:1. dysfunction in Hypothalamic - pituitary - gonadal axis 2. Simultaneous presence of active malignancy with different origin 3. Require the other treatments (chemotherapy, radiotherapy) 4.Inability to obtain consent due to dissatisfaction or intellectual problems
  • 5. History of hypersensitivity to GnRH, GnRH analogs 6. History of bilateral orchiectomy

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research Tehran University of Medical Sciences

相似试验